stockrowCorcept Therapeutics Incorporated
CORT Healthcare Biotechnology
Corcept Therapeutics Incorporated’s revenue for fiscal 2025 (year ended December 2025) was $761.4 million, up 12.8% from fiscal 2024.
- Revenue
- +64.0%
- EPS
- +525.8%
- Free cash flow
- +161.0%
Quarter to September 2026, against a year earlier
Follow CORT
Alert me
Corcept Therapeutics Incorporated (CORT) Revenue growth
Corcept Therapeutics Incorporated's revenue growth over the twelve months to 30 September 2026 was 30.0%, up 17.2 percentage points from fiscal 2025 (12.8%). Over the past ten years it has ranged from 3.42% (fiscal 2021) to 95.8% (fiscal 2017); the current reading is higher than 27% of that period. That is above the Biotechnology industry median of 6.26% and above the Healthcare sector median of 7.80%.
Revenue growth, annual
Embed this chart
Annual newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| FY2025 | 12.8% | (27.15) |
| FY2024 | 39.9% | 19.90 |
| FY2023 | 20.0% | 10.24 |
| FY2022 | 9.80% | 6.38 |
| FY2021 | 3.42% | (12.04) |
| FY2020 | 15.5% | (6.53) |
| FY2019 | 22.0% | (35.83) |
| FY2018 | 57.8% | (37.95) |
| FY2017 | 95.8% | 34.05 |
| FY2016 | 61.7% | (27.67) |
Quarterly newest first
| Period | Revenue growth | Change (points) |
|---|---|---|
| Sep 2026 | 64.0% | 32.23 |
| Jun 2026 | 31.7% | 26.85 |
| Mar 2026 | 4.89% | (6.23) |
| Dec 2025 | 11.1% | (2.63) |
| 43 more quarters | Free account |
Against its own ten years
Revenue growth against peers
| Company | Revenue growth |
|---|---|
| PRAX Praxis Precision Medicines, Inc. compare | 249.5% |
| MDGL Madrigal Pharmaceuticals, Inc. compare | 92.8% |
| PTGX Protagonist Therapeutics, Inc. compare | 34.8% |
| CORT Corcept Therapeutics Incorporated | 30.0% |
| CYTK Cytokinetics, Incorporated compare | 29.9% |
| KRYS Krystal Biotech, Inc. compare | 26.0% |
| ARWR Arrowhead Pharmaceuticals, Inc. compare | 16.1% |
| SYRE Spyre Therapeutics, Inc. compare | −81.8% |
| ABVX Abivax SA Sponsored ADR compare | — |
| Biotechnology industry median | 6.26% |
| Healthcare sector median | 7.80% |
| Market median | 7.58% |
What Revenue growth is
Revenue Growth shows how fast a company’s sales are rising or falling compared with the same period a year earlier.
(Revenue − Revenue a year earlier) ÷ |Revenue a year earlier|
More on CORT
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement